The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,090.00
Bid: 1,096.00
Ask: 1,098.00
Change: -1.00 (-0.09%)
Spread: 2.00 (0.182%)
Open: 1,099.00
High: 1,112.00
Low: 1,089.00
Prev. Close: 1,091.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Secondary Placing

5 Mar 2012 07:00

RNS Number : 6614Y
Dunelm Group plc
05 March 2012
 



Dunelm Group plc

5 March 2012

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

PROPOSED SECONDARY PLACING OF ORDINARY SHARES IN DUNELM GROUP PLC ("DUNELM" OR "THE COMPANY")

Dunelm announces that it has been advised by Will Adderley, Executive Deputy Chairman of the Company, and his wife, Nadine Adderley, that they intend to sell approximately 5 million ordinary shares in the Company in aggregate via an accelerated bookbuild secondary placing (the "Placing"). This represents in aggregate approximately 2.5 per cent of the issued share capital of Dunelm.

The Company has been advised that this proposed sale is aimed at achieving greater portfolio diversification on the part of Will and Nadine Adderley.

 

Assuming that the above number of shares were sold, Will Adderley would continue to have an interest in 65.5 million shares in the Company, representing 32.4 per cent of the issued share capital. The Adderley family as a whole would retain a combined interest in 113.6 million shares in the Company, representing 56.2 per cent of the issued share capital.

 

Will Adderley remains fully committed to Dunelm in his role as Executive Deputy Chairman as well as a very substantial shareholder in the Company.

 

The Placing will be managed by UBS, acting as Bookrunner, and Oriel Securities, acting as Co-Lead Manager. The amount of the Placing proceeds, the number of ordinary shares in the Placing ("Placing Shares") and the placing price will be decided at the close of the accelerated bookbuilding period.

Under the terms of the placing agreement, Will and Nadine Adderley have agreed that, following completion of the Placing, they will not dispose of further shares in the Company for a period of at least six months.

The books for the Placing will open with immediate effect. Pricing and allocations are expected to be announced as soon as practicable following the closing of the books. The timing of closing of the books will be at the absolute discretion of UBS.

 

Enquiries:

UBS +44 (0)20 7567 8000

Craig Calvert

Christopher Smith

Oriel Securities +44 (0)20 7710 7600

Nicholas How

David Arch

 

MHP Communications +44 (0) 20 3128 8100

John Olsen

Simon Hockridge

 

Each of UBS Limited and Oriel Securities is acting on the Placing and will not be responsible to anyone other than its client for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Dunelm, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia or Japan. Dunelm's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

Dunelm's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia or Japan or offered or sold to a resident of Canada, Australia or Japan. No public offering of securities is being made in the United States.

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada or Japan or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian or Japanese securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/ec and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSWSMIFESELD
Date   Source Headline
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20223:30 pmRNSResults of AGM
30th Nov 20227:00 amRNSConfirmation of Chair Succession
23rd Nov 20227:00 amRNSGrant of options
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
4th Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20227:00 amRNSAnnual Report and Accounts and Notice of AGM
20th Oct 20227:00 amRNSFirst quarter trading update
10th Oct 20227:00 amRNSBlock listing Six Monthly Return
10th Oct 20227:00 amRNSBlock listing Six Monthly Return
10th Oct 20227:00 amRNSBlock listing Six Monthly Return
10th Oct 20227:00 amRNSBlock listing Six Monthly Return
10th Oct 20227:00 amRNSBlock listing Six Monthly Return
3rd Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSPurchase of shares during open periods
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSPreliminary Results
8th Sep 20227:00 amRNSIntention to conduct audit tender
7th Sep 20227:00 amRNSConfirmation of Board Change
6th Sep 20221:20 pmRNSDirector Declaration
31st Aug 20224:05 pmRNSHolding(s) in Company
31st Aug 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSHolding(s) in Company
8th Aug 20221:59 pmRNSDirector/PDMR Shareholding
8th Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSTotal Voting Rights
21st Jul 20227:02 amRNSAppointment of Independent NED and Chair Designate
21st Jul 20227:02 amRNSFull year trading update
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.